Caplin Point Laboratories

I would like to draw your attention on AR of FY2021-22
Page 23
At Caplin Point Laboratories, our action plan for next six years is as under:

1. The top line of FY 2021-22 (Rs 1308Cr) will be the bottom line of FY 2027-28.( Assume same number of Equity share i.e.7.594 Cr then EPS 172)
2. Caplin would be present in most of the major regulated markets by 2027-28.
3. Caplin would have facilities for all dosage forms for regulated markets.
   4 the Company to reach where it is now would continue as a COURSE TO STAY ON while we keep on adding state-of-the-art technology, equipment, skills and products.
4. Caplin would be one among the top 30 Indian companies in the pharma sector.
5. Caplin would STAY ON COURSE to cater to the BOTTOM OF THE
   PYRAMID and BOTTOMOFTHEBUSINESSPYRAMID in most of
   the markets where we would be present.
   7.Caplin would have different buckets of formulations in a big basket to create the “stock & sale model” next to the customers in various markets.
   Strong Distribution Model

As per my understanding with its business or thumb rules to be followed
GP: 55-57%
EBITDA: 35-36%
PAT 25% ± 1%